Advertisement
Predictive Oncology Inc. (POAI)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
| Previous Close | 0.7133 |
| Open | 0.7200 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.7112 - 0.8780 |
| 52 Week Range | 0.5500 - 3.7600 |
| Volume | |
| Avg. Volume | 149,279 |
| Market Cap | 5.574M |
| Beta (5Y Monthly) | 1.13 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.3400 |
| Earnings Date | Nov 12, 2024 - Nov 18, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.00 |
GuruFocus.comPredictive Oncology Inc (POAI) Q2 2024 Earnings Call Highlights: Strategic Advances Amidst ...
Despite a decline in revenue, Predictive Oncology Inc (POAI) strengthens its AI capabilities and financial position through strategic initiatives and collaborations.
GlobeNewswirePredictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PITTSBURGH, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, is scheduled to deliver a virtual presentation and host investor one-on-one meetings at the H.C. Wainwright 26th Annual Global Investment Conference, which is being held September 9th through 11th in New York, NY. Management’s presentation will be available on-demand beginning on Monday, September 9th at 7:00 am (ET) via the conference platform. The Predicti
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.